| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |